by Hannah Baratham-Green Reporter, Boston Business Journal Read the full article
Category Archives: News
Cilcare steps up its US expansion: Clinical trial at MGH, threefold capacity growth with CBSET, and launch of a gateway for foreign biotechs entering the American market
National Harbor, MD — May 5, 2026 — Cilcare, a French-US biopharmaceutical company specializing in auditory science, today announced a series of major investments in the United States at the SelectUSA Investment Summit 2026. At a glance: 1. Clinical trial of CIL001 in tinnitus initiated at Massachusetts General Hospital (Mass Eye & Ear Boston) 2. […]
CBSET Expands Leadership Team, Welcoming Michael C. John as Chief Regulatory and Innovation Officer (CRIO)
New role expands CBSET’s offerings to include professional consulting and FDA regulatory advisory services, and accelerates strategic diversification into new sectors LEXINGTON, MA, January 26, 2026 — CBSET, a leading provider of translational research and product development services for the medical device, pharmaceutical, diagnostic, and biomedical research industries, is excited to announce the hiring of […]
Press Release: Arlington Capital Partners Announces Majority Growth Investment in CBSET
The partnership will help CBSET scale its integrated preclinical research & testing platform through significant capacity expansion and strategic add-on acquisitions Washington, DC – October 1, 2025 – Arlington Capital Partners (“Arlington”), a Washington, D.C.-area private investment firm specializing in government regulated industries, today announced it has completed a majority growth investment in Concord Biomedical […]
Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System
GLP study marks a key milestone in Autonomix’s path to achieve regulatory approvals Company remains on track to submit Investigational Device Exemption (“IDE”), and if approved, commence U.S. clinical trials in 2026 to support a De Novo FDA application THE WOODLANDS, TX, Sept. 29, 2025 — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a […]
CBSET playing a key role in advancing biomedical innovation in Massachusetts
June 17, 2025: The Biotechnology Innovation Organization (BIO) named Massachusetts Governor Maura Healey its 2025 Governor of the Year, recognizing her leadership in advancing biotechnology as a cornerstone of the state’s economy and her commitment to strengthening Massachusetts’s position as a global leader in the field. Since its founding in 2007, CBSET has played a […]
DeepQure Presents Laparoscopic RDN Research Results at CRT 2025
DeepCure Presents Laparoscopic RDN Research Results at CRT 2025 DeepQure, a company specializing in laparoscopic renal denervation (RDN) devices, announced on the 10th that it participated in the Cardiovascular Research Technology (CRT) conference ‘CRT 2025’ held in Washington, D.C., USA on the 8th. CRT 2025 is a globally renowned academic conference in cardiovascular research and […]
DeepQure Presents Clinical Results of Laparoscopic RDN at TCT 2024, Demonstrating Cutting-edge Technology and Innovation
DeepQure Presents Clinical Results of Laparoscopic RDN at TCT 2024, Demonstrating Cutting-edge Technology and Innovation SEOUL, South Korea, Oct. 29, 2024 — DeepQure, a global pioneer in resistant hypertension treatment, has unveiled clinical results of its laparoscopic renal denervation (RDN) medical device “HyperQure”. Designed to treat resistant hypertension, HyperQure uses a laparoscopic approach to block the […]
DECODE Network Meeting 5: Medical Device Testing during the innovation cycle – Impressions of an ESR7
DECODE Network Meeting 5 – “Medical Device Testing during the innovation cycle” – Impressions of an ESR7 by Leo Benolić (ESR7, BioIRC) From April 17th to 19th, 2024, CBSET hosted its fifth network meeting, focusing on “Medical Device Testing during the Innovation Cycle.” The event brought together a diverse group of experts and emerging researchers […]
CBSET Welcomes Efstathios Stratakos, Sept 1, 2023
CBSET welcomes ESR6 Efstathios Stratakos, an early-stage DECODE researcher. About Efstathios Stratakos Host: Politecnico di Milano In silico simulations at macro/meso scale of angioplasty with DCBs, focusing on the mechanical aspects at the balloon-vessel interface (WP3, WP4) Efstathios Stratakos received the Integrated Master’s Degree in Mechanical Engineering and Aeronautics from the University of Patras with […]